Aarti Drugs Q4 Results

  • BSE: 524348
  • NSE: AARTIDRUGS
  • ISIN: INE767A01016
  • Sector: Biotechnology & Drugs
BSE
453.74.70 (1.05%)
Volume5.95 K
Updated: Mon 25 Nov, 2024 | 15:52:55
NSE
453.13.85 (0.86%)
Volume1.36 L
Updated: Mon 25 Nov, 2024 | 15:31:33
Today: 451.55
460.90
52-Wk: 430.00
634.90

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Aarti Drugs Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 619.99663.96-%742.41-%
    Selling/ General/ Admin Expenses Total 25.8723.68-%25.46-%
    Depreciation/ Amortization 13.5812.62-%12.50-%
    Other Operating Expenses Total 111.21106.73-%107.90-%
    Total Operating Expense 547.76605.94-%661.38-%
    Operating Income 72.2358.02-%81.03-%
    Net Income Before Taxes 64.1849.68-%73.28-%
    Net Income 47.3736.69-%56.09-%
    Diluted Normalized EPS 5.153.96-%6.06-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts